ADORA2A and neoplasm: Expression of A2AR and A2BR on dendritic cells has been reported previously50 and blockade of A2BR or CD739,51 or myeloid-specific deletion of A2AR or A2BR has been shown to enhance anti-tumor immunity27,52 in part through modulation of DC function53.